Cardiovascular Toxicity of Biologie Agents for Cancer Therapy.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Works matching IS 08909091 AND DT 2014 AND VI 28 AND IP 6
Results: 18
1
2
Double Trouble: A Case of Concurrent De Novo T790M and L858R EGFR Mutations in Treatment-Naive Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 526
- By:
- Publication type:
- Article
3
The Role of Radical Prostatectomy and Lymph Node Dissection in the Treatment of Young Men With High-Grade Node-Positive Prostate Cancer: Less Is More--the Benefits of Surgery Do Not Yet Outweigh Potential Harms.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 523
- By:
- Publication type:
- Article
4
Survivorship Is Not a Passive Sport.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 533
- By:
- Publication type:
- Article
5
Best of the Blogs.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 532
- By:
- Publication type:
- Article
6
Cardiotoxicity of Targeted Agents in Oncology: A Medical Oncology Perspective.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
7
Consider a Single Intraoperative Fraction for Patients Eligible for Hypofractionated Regimens?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 550
- By:
- Publication type:
- Article
8
Hypofractionation for Breast Cancer: Lessons Learned From Our Neighbors to the North and Across the Pond.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 536
- By:
- Publication type:
- Article
9
Fractionation in Breast Cancer Radiotherapy for Conservative Treatment: Are We Really Done Learning?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 546
- By:
- Publication type:
- Article
10
EGJ and Esophageal Cancers: Choosing Induction Therapy so as to Err on the Side of Overtreatment Rather Than Undertreatment When Staging Is Imperfect.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 512
- By:
- Publication type:
- Article
11
Cardiovascular Toxicity of Biologic Agents for Cancer Therapy.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 482
- By:
- Publication type:
- Article
12
The Role of Radical Prostatectomy and Lymph Node Dissection in the Treatment of Young Men With High-Grade Node-Positive Prostate Cancer: There May Be No RCTs--but There Are Good Reasons to Include Surgery.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 522
- By:
- Publication type:
- Article
13
Salvage Chemotherapy for Refractory Germ Cell Tumors.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 498
- By:
- Publication type:
- Article
14
Esophagogastric Junction and Gastric Adenocarcinoma: Current Challenges and Future Directions.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 520
- By:
- Publication type:
- Article
15
Esophagogastric Junction and Gastric Adenocarcinoma: Neoadjuvant and Adjuvant Therapy, and Future Directions.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 505
- By:
- Publication type:
- Article
16
It's Time to Have 'The Talk': Cost Communication and Patient-Centered Care.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 479
- By:
- Publication type:
- Article
17
Cardiovascular Toxicity of Newer Chemotherapeutic Agents: The Heart of the Matter.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 493
- By:
- Publication type:
- Article
18
The Challenge of Managing Increasingly Complex Cancer Toxicity.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 454
- By:
- Publication type:
- Article